Regenicin Inc. | Income Statement
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
SG&A Expense
997.80
725.90
1,215.20
1,195.90
976.10
789.10
EBIT
997.80
725.90
1,215.20
1,195.90
976.10
789.10
Unusual Expense
3,140.40
269.40
2,254.90
123.60
15.00
248.80
Non Operating Income/Expense
-
-
6,604.40
-
-
-
Interest Expense
766.70
232.40
62.80
17.50
17.50
18.80
Pretax Income
4,904.80
688.90
3,071.60
1,089.90
973.90
559.10
Income Tax
-
2,829.00
2,829.00
-
-
-
Consolidated Net Income
4,904.80
2,140.10
242.60
1,089.90
973.90
559.10
Net Income
4,904.80
2,140.10
242.60
1,089.90
973.90
559.10
Net Income After Extraordinaries
4,904.80
2,140.10
242.60
1,089.90
973.90
559.10
Net Income Available to Common
4,951.00
2,069.30
171.80
1,160.90
1,044.70
629.90
EPS (Basic)
0.05
0.02
0.00
0.01
0.01
-
Basic Shares Outstanding
109,139.70
132,966.50
153,262.90
153,483.10
153,483.10
153,483.10
EPS (Diluted)
0.05
0.01
0.00
0.01
0.01
-
Diluted Shares Outstanding
109,139.70
191,425.80
162,114.40
153,483.10
153,483.10
153,483.10
EBITDA
997.80
725.90
1,215.20
1,195.90
976.10
789.10
Non-Operating Interest Income
-
-
-
-
4.70
-
Preferred Dividends
46.20
70.80
70.80
71.00
70.80
70.80
About Regenicin
View Profile
